The role of physical exercise in inflammatory bowel disease

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Bilski, Jan ^a   Brzozowski, Bartosz ^a   Mazur Bialy, Agnieszka ^a   Sliwowski, Zbigniew ^a   Brzozowski, Tomasz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE; CROHN DISEASE; ENVIRONMENTAL FACTOR; EXERCISE; GENETIC PREDISPOSITION; HUMAN; HYPERTROPHY; INFLAMMATORY BOWEL DISEASE; NONHUMAN; PHYSICAL ACTIVITY; REVIEW; RISK FACTOR; TRAINING; TREADMILL EXERCISE; ULCERATIVE COLITIS; WHITE ADIPOSE TISSUE; FEMALE; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTRAABDOMINAL FAT; KINESIOTHERAPY; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ADIPOCYTOKINE; AUTACOID;

ADIPOKINES; EXERCISE; EXERCISE THERAPY; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; INTRA-ABDOMINAL FAT; MALE;

EID: 84901249180     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/429031     Document Type: Review

References (139)

1. Beavers K. M., Brinkley T. E., Nicklas B. J., Effect of exercise training on chronic inflammation. Clinica Chimica Acta 2010 411 11-12 785 793 2-s2.0-77954192215
2. Shanahan F., Crohn's disease. The Lancet 2002 359 9300 62 69 2-s2.0-0037022008 10.1016/S0140-6736(02)07284-7 (Pubitemid 34119201)
3. Terzić J., Grivennikov S., Karin E., Karin M., Inflammation and colon cancer. Gastroenterology 2010 138 6 2101 2114 2-s2.0-77951635438 10.1053/j.gastro.2010.01.058
4. Baumgart D. C., Sandborn W. J., Inflammatory bowel disease: clinical aspects and established and evolving therapies. The Lancet 2007 369 9573 1641 1657 2-s2.0-34248136340 10.1016/S0140-6736(07)60751-X (Pubitemid 46722637)
5. Sartor R. B., Mechanisms of disease: Pathogenesis of Crohn's disease and ulcerative colitis. Nature Clinical Practice Gastroenterology and Hepatology 2006 3 7 390 407 2-s2.0-33745775434 10.1038/ncpgasthep0528 (Pubitemid 44018812)
6. Strober W., Fuss I. J., Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011 140 6 1756 1767 2-s2.0-79955563439 10.1053/j.gastro.2011.02.016
7. Strober W., Zhang F., Kitani A., Fuss I., Fichtner-Feigl S., Proinflammatory cytokines underlying the inflammation of Crohn's disease. Current Opinion in Gastroenterology 2010 26 4 310 317 2-s2.0-77954142663 10.1097/MOG.0b013e328339d099
8. Dohi T., Borodovsky A., Wu P., Shearstone J. R., Kawashima R., Runkel L., Rajman L., Dong X., Scott M. L., Michaelson J. S., Jakubowski A., Burkly L. C., TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis. Gastroenterology 2009 136 3 912 923 2-s2.0-60449110144 10.1053/j.gastro.2008.11.017
9. Dohi T., Burkly L. C., The TWEAK/Fn14 pathway as an aggravating and perpetuating factor in inflammatory diseases: focus on inflammatory bowel diseases. Journal of Leukocyte Biology 2012 92 2 265 279 10.1189/jlb.0112042
10. Son A., Oshio T., Kawamura Y. I., TWEAK/Fn14 pathway promotes a T helper 2-type chronic colitis with fibrosis in mice. Mucosal Immunology 2013 6 6 1131 1142 10.1038/mi.2013.10
11. Burkly L. C., Dohi T., The TWEAK/Fn14 pathway in tissue remodeling: for better or for worse. Advances in Experimental Medicine and Biology 2011 691 305 322 2-s2.0-79954449374 10.1007/978-1-4419-6612-4-32
12. Caspersen C. J., Powell K. E., Christenson G., Physical activity, exercise and physical fitness: definitions and distinctions for health-related research. Public Health Reports 1985 100 2 126 131 2-s2.0-0021798918 (Pubitemid 15064369)
13. Wilund K. R., Is the anti-inflammatory effect of regular exercise responsible for reduced cardiovascular disease? Clinical Science 2007 112 11-12 543 555 2-s2.0-34249829594 10.1042/CS20060368 (Pubitemid 46849545)
14. Hoffman-Goetz L., Pedersen B. K., Exercise and the immune system: a model of the stress response? Immunology Today 1994 15 8 382 387 2-s2.0-0027994215 10.1016/0167-5699(94)90177-5 (Pubitemid 24246912)
15. Pedersen B. K., Nieman D. C., Exercise immunology: integration and regulation. Immunology Today 1998 19 5 204 206 2-s2.0-0031837284 10.1016/S0167-5699(98)01255-9 (Pubitemid 28278251)
16. Fitzgerald L., Exercise and the immune system. Immunology Today 1988 9 11 337 339 2-s2.0-0023686989
17. Bartram S. A., Peaston R. T., Rawlings D. J., Walshaw D., Francis R. M., Thompson N. P., Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease. World Journal of Gastroenterology 2006 12 35 5680 5686 2-s2.0-33750130080 (Pubitemid 44594044)
18. Walsh N. P., Gleeson M., Pyne D. B., Nieman D. C., Dhabhar F. S., Shephard R. J., Oliver S. J., Bermon S., Kajeniene A., Position statement part two: maintaining immune health. Exercise Immunology Review 2011 17 64 103 2-s2.0-79953785427
19. Walsh N. P., Gleeson M., Shephard R. J., Position statement. Part one: immune function and exercise. Exercise Immunology Review 2011 17 6 63
20. Ho G. W. K., Lower gastrointestinal distress in endurance athletes. Current Sports Medicine Reports 2009 8 2 85 91 2-s2.0-67649353150 10.1249/JSR.0b013e31819d6b7b
21. Kruk J., Czerniak U., Physical activity and its relation to cancer risk: updating the evidence. Asian Pacific Organization for Cancer Prevention 2013 14 7 3993 4003
22. Ng V., Millard W., Lebrun C., Howard J., Exercise and Crohn's disease: speculations on potential benefits. Canadian Journal of Gastroenterology 2006 20 10 657 660 2-s2.0-33751213352 (Pubitemid 44781904)
23. Pérez C. A., Prescription of physical exercise in Crohn's disease. Journal of Crohn's and Colitis 2009 3 4 225 231 2-s2.0-70350618464 10.1016/j.crohns.2009.08.006
24. Narula N., Fedorak R. N., Exercise and inflammatory bowel disease. Canadian Journal of Gastroenterology 2008 22 5 497 504 2-s2.0-46749118826 (Pubitemid 351943679)
25. Packer N., Hoffman-Goetz L., Ward G., Does physical activity affect quality of life, disease symptoms and immune measures in patients with inflammatory bowel disease? A systematic review. Journal of Sports Medicine and Physical Fitness 2010 50 1 1 18 2-s2.0-77952940655
26. Cosnes J., Gowerrousseau C., Seksik P., Cortot A., Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011 140 6 1785 1794 2-s2.0-79955561083 10.1053/j.gastro.2011.01.055
27. Lobstein T., Baur L., Uauy R., Obesity in children and young people: a crisis in public health. Obesity Reviews 2004 5 supplement 1 4 104 2-s2.0-3242765196 (Pubitemid 38967209)
28. Sonnenberg A., Occupational distribution of inflammatory bowel disease among German employees. Gut 1990 31 9 1037 1040 2-s2.0-0025140867 (Pubitemid 20295942)
29. Persson P.-G., Leijonmarck C.-E., Bernell O., Hellers G., Ahlbom A., Risk indicators for inflammatory bowel disease. International Journal of Epidemiology 1993 22 2 268 272 2-s2.0-0027287382 (Pubitemid 23129328)
30. Boggild H., Tuchsen F., Orhede E., Occupation, employment status and chronic inflammatory bowel disease in Denmark. International Journal of Epidemiology 1996 25 3 630 637 (Pubitemid 26229566)
31. Klein I., Reif S., Farbstein H., Halak A., Gilat T., Preillness non dietary factors and habits in inflammatory bowel disease. Italian Journal of Gastroenterology and Hepatology 1998 30 3 247 251 2-s2.0-0031853402 (Pubitemid 28395732)
32. Cucino C., Sonnenberg A., Occupational mortality from inflammatory bowel disease in the United States 1991-1996. The American Journal of Gastroenterology 2001 96 4 1101 1105 2-s2.0-0035048939 10.1016/S0002-9270(01)02310-3 (Pubitemid 32319143)
33. Halfvarson J., Jess T., Magnuson A., Montgomery S. M., Orholm M., Tysk C., Binder V., Järnerot G., Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflammatory Bowel Diseases 2006 12 10 925 933 2-s2.0-33749341758 10.1097/01.mib.0000228998.29466.ac (Pubitemid 44498280)
34. Chan S. S., Luben R., Olsen A., Body mass index and the risk for Crohn's disease and ulcerative colitis: data from a European Prospective Cohort Study (The IBD in EPIC Study). The American Journal of Gastroenterology 2013 108 4 575 582 10.1038/ajg.2012.453
35. Hlavaty T., Toth J., Koller T., Smoking, breastfeeding, physical inactivity, contact with animals, and size of the family influence the risk of inflammatory bowel disease: a Slovak case-control study. United European Gastroenterology Journal 2013
36. Khalili H., Ananthakrishnan A. N., Konijeti G. G., Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts. British Medical Journal 2013 347 10.1136/bmj.f6633
37. Bilski J., Mazur-Bialy A. I., Wierdak M., The impact of physical activity and nutrition on inflammatory bowel disease: the potential role of cross talk between adipose tissue and skeletal muscle. The Journal of Physiology and Pharmacology 2013 64 2 143 155
38. Loudon C. P., Corroll V., Butcher J., Rawsthorne P., Bernstein C. N., The effects of physical exercise on patients with Crohn's disease. The American Journal of Gastroenterology 1999 94 3 697 703 2-s2.0-0033017638 10.1016/S0002-9270(98)00820-X (Pubitemid 29124869)
39. Ng V., Millard W., Lebrun C., Howard J., Low-intensity exercise improves quality of life in patients with Crohn's disease. Clinical Journal of Sport Medicine 2007 17 5 384 388 2-s2.0-34548701062 10.1097/JSM.0b013e31802b4fda
40. Gupta N., Khera S., Vempati R. P., Sharma R., Bijlani R. L., Effect of yoga based lifestyle intervention on state and trait anxiety. Indian Journal of Physiology and Pharmacology 2006 50 1 41 47 2-s2.0-31344478515 (Pubitemid 43145178)
41. Nathan I., Norton C., Czuber-Dochan W., Exercise in individuals with inflammatory bowel disease. Gastroenterology Nursing 2013 36 6 437 442 10.1097/SGA.0000000000000005
42. D'Incà R., Varnier M., Mestriner C., Martines D., D'Odorico A., Sturniolo G. C., Effect of moderate exercise on Crohn's disease patients in remission. Italian Journal of Gastroenterology and Hepatology 1999 31 3 205 210 2-s2.0-0033034319 (Pubitemid 29248563)
43. Nic S. T., Raftery T. C., McMahon O., High prevalence of overweight and obesity in adults with Crohn's disease: associations with disease and lifestyle factors. Journal of Crohn's and Colitis 2013 7 7 e241 e248
44. Ploeger H., Obeid J., Nguyen T., Takken T., Issenman R., de Greef M., Timmons B., Exercise and inflammation in pediatric Crohn's disease. International Journal of Sports Medicine 2012 33 8 671 679 2-s2.0-84860387815 10.1055/s-0032-1304323
45. Chan D., Robbins H., Rogers S., Inflammatory bowel disease and exercise: results of a Crohn's and Colitis UK survey. Frontline Gastroenterology 2014 5 1 44 48 10.1136/flgastro-2013-100339
46. Cook M. D., Martin S. A., Williams C., Forced treadmill exercise training exacerbates inflammation and causes mortality while voluntary wheel training is protective in a mouse model of colitis. Brain, Behavior, and Immunity 2013 46 56 10.1016/j.bbi.2013.05.005
47. Shi X.-Z., Winston J. H., Sarna S. K., Differential immune and genetic responses in rat models of Crohn's colitis and ulcerative colitis. American Journal of Physiology: Gastrointestinal and Liver Physiology 2011 300 1 G41 G51 2-s2.0-78650798979 10.1152/ajpgi.00358.2010
48. Saxena A., Fletcher E., Larsen B., Effect of exercise on chemically-induced colitis in adiponectin deficient mice. Journal of Inflammation 2012 9 1, article 30 10.1186/1476-9255-9-30
49. Hoffman-Goetz L., Pervaiz N., Packer N., Guan J., Freewheel training decreases pro- and increases anti-inflammatory cytokine expression in mouse intestinal lymphocytes. Brain, Behavior, and Immunity 2010 24 7 1105 1115 2-s2.0-84755161372 10.1016/j.bbi.2010.05.001
50. Hoffman-Goetz L., Thorne R. J., Houston M. E., Splenic immune responses following treadmill exercise in mice. Canadian Journal of Physiology and Pharmacology 1988 66 11 1415 1419 2-s2.0-0024234432 (Pubitemid 19024385)
51. Hoffman-Goetz L., Spagnuolo P. A., Guan J., Repeated exercise in mice alters expression of IL-10 and TNF- α in intestinal lymphocytes. Brain, Behavior, and Immunity 2008 22 2 195 199 2-s2.0-37349125963 10.1016/j.bbi.2007. 07.002 (Pubitemid 350299800)
52. Luo B., Xiang D., Nieman D. C., The effects of moderate exercise on chronic stress-induced intestinal barrier dysfunction and antimicrobial defense. Brain, Behavior, and Immunity 2013 10.1016/j.bbi.2013.11.013
53. Kappelman M. D., Rifas-Shiman S. L., Kleinman K., Ollendorf D., Bousvaros A., Grand R. J., Finkelstein J. A., The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clinical Gastroenterology and Hepatology 2007 5 12 1424 1429 2-s2.0-36549001139 10.1016/j.cgh.2007.07.012 (Pubitemid 350181588)
54. Pedersen B. K., Febbraio M. A., Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nature Reviews Endocrinology 2012 8 8 457 465 2-s2.0-84859095015 10.1038/nrendo.2012.49
55. Sheehan A. L., Warren B. F., Gear M. W. L., Shepherd N. A., Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice. British Journal of Surgery 1992 79 9 955 958 2-s2.0-0026783098 10.1002/bjs.1800790934
56. Peyrin-Biroulet L., Gonzalez F., Dubuquoy L., Rousseaux C., Dubuquoy C., Decourcelle C., Saudemont A., Tachon M., Béclin E., Odou M.-F., Neut C., Colombel J.-F., Desreumaux P., Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease. Gut 2012 61 1 78 85 2-s2.0-83555177321 10.1136/gutjnl-2011-300370
57. Peyrin-Biroulet L., Chamaillard M., Gonzalez F., Beclin E., Decourcelle C., Antunes L., Gay J., Neut C., Colombel J.-F., Desreumaux P., Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander? Gut 2007 56 4 577 583 2-s2.0-34147213316 10.1136/gut.2005.082925 (Pubitemid 46580516)
58. Kaser A., Tilg H., "Metabolic aspects" in inflammatory bowel diseases. Current Drug Delivery 2012 9 4 326 332 10.2174/156720112801323044
59. Batra A., Heimesaat M. M., Bereswill S., Mesenteric fat-control site for bacterial translocation in colitis? Mucosal Immunology 2012 5 5 580 591
60. Fink C., Karagiannides I., Bakirtzi K., Pothoulakis C., Adipose tissue and inflammatory bowel disease pathogenesis. Inflammatory Bowel Diseases 2012 18 8 1550 1557 2-s2.0-84857955303 10.1002/ibd.22893
61. Drouet M., Dubuquoy L., Desreumaux P., Bertin B., Visceral fat and gut inflammation. Nutrition 2012 28 2 113 117 2-s2.0-84855238311 10.1016/j.nut.2011.09.009
62. Acedo S. C., Gotardo É. M. F., Lacerda J. M., de Oliveira C. C., de Oliveira Carvalho P., Gambero A., Perinodal adipose tissue and mesenteric lymph node activation during reactivated TNBS-colitis in rats. Digestive Diseases and Sciences 2011 56 9 2545 2552 2-s2.0-80054728419 10.1007/s10620-011-1644-8
63. Kredel L. I., Batra A., Stroh T., Kühl A. A., Zeitz M., Erben U., Siegmund B., Adipokines from local fat cells shape the macrophage compartment of the creeping fat in Crohn's disease. Gut 2013 62 6 852 862 2-s2.0-84860215194 10.1136/gutjnl-2011-301424
64. Jung S. H., Saxena A., Kaur K., The role of adipose tissue-associated macrophages and T lymphocytes in the pathogenesis of inflammatory bowel disease. Cytokine 2013 61 2 459 468 10.1016/j.cyto.2012.11.021
65. Monteleone G., Pallone F., MacDonald T. T., Emerging immunological targets in inflammatory bowel disease. Current Opinion in Pharmacology 2011 11 6 640 645 2-s2.0-82255175757 10.1016/j.coph.2011.09.013
66. MacDonald T. T., Monteleone I., Fantini M. C., Monteleone G., Regulation of homeostasis and inflammation in the intestine. Gastroenterology 2011 140 6 1768 1775 2-s2.0-79955551587 10.1053/j.gastro.2011.02.047
67. Mowat A. M., Bain C. C., Mucosal macrophages in intestinal homeostasis and inflammation. Journal of Innate Immunity 2011 3 6 550 564 2-s2.0-80054882496 10.1159/000329099
68. Roberts-Thomson I. C., Fon J., Uylaki W., Cummins A. G., Barry S., Cells, cytokines and inflammatory bowel disease: a clinical perspective. Expert Review of Gastroenterology and Hepatology 2011 5 6 703 716 2-s2.0-80155182156 10.1586/egh.11.74
69. Cho J. H., The genetics and immunopathogenesis of inflammatory bowel disease. Nature Reviews Immunology 2008 8 6 458 466 2-s2.0-44349124113 10.1038/nri2340 (Pubitemid 351733422)
70. Shelley-Fraser G., Borley N. R., Warren B. F., Shepherd N. A., The connective tissue changes of Crohn's disease. Histopathology 2011 2-s2.0-80054118274 10.1111/j.1365-2559.2011.03911.x
71. Borley N. R., Mortensen N. J., Jewell D. P., The relationship between inflammatory and serosal connective tissue changes in ileal Crohn's disease: evidence for a possible causative link. The Journal of Pathology 2000 190 2 196 202 10.1002/(SICI)1096-9896(200002)190:2<196::AID-PATH513>3.0. CO;2-5 (Pubitemid 30082494)
72. Olivier I., Théodorou V., Valet P., Castan-Laurell I., Guillou H., Bertrand-Michel J., Cartier C., Bezirard V., Ducroc R., Segain J.-P., Portier G., Kirzin S., Moreau J., Duffas J.-P., Ferrier L., Eutamaène H., Is Crohn's creeping fat an adipose tissue? Inflammatory Bowel Diseases 2011 17 3 747 757 2-s2.0-79951633581 10.1002/ibd.21413
73. McCaskey S. J., Rondini E. A., Langohr I. M., Fenton J. I., Differential effects of energy balance on experimentally-induced colitis. World Journal of Gastroenterology 2012 18 7 627 636 2-s2.0-84857417374 10.3748/wjg.v18.i7.627
74. Ponemone V., Keshavarzian A., Brand M. I., Apoptosis and inflammation: role of adipokines in inflammatory bowel disease. Clinical and Translational Gastroenterology 2010 1 10, article e1 10.1038/ctg.2010.1
75. Biesiada G., Czepiel J., Ptak-Belowska A., Expression and release of leptin and proinflammatory cytokines in patients with ulcerative colitis and infectious diarrhea. The Journal of Physiology and Pharmacology 2012 63 5 471 481
76. Barbier M., Vidal H., Desreumaux P., Dubuquoy L., Bourreille A., Colombel J.-F., Cherbut C., Galmiche J.-P., Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases. Gastroenterologie Clinique et Biologique 2003 27 11 987 991 2-s2.0-0344739789 (Pubitemid 37516823)
77. Barbier M., Cherbut C., Aubé A. C., Blottière H. M., Galmiche J. P., Elevated plasma leptin concentrations in early stages of experimental intestinal inflammation in rats. Gut 1998 43 6 783 790 2-s2.0-0031768795 (Pubitemid 28539657)
78. Singh U. P., Singh N. P., Guan H., Leptin antagonist ameliorates chronic colitis in IL-10-/- mice. Immunobiology 2013 218 12 1439 1451
79. Yamamoto K., Kiyohara T., Murayama Y., Kihara S., Okamoto Y., Funahashi T., Ito T., Nezu R., Tsutsui S., Miyagawa J.-I., Tamura S., Matsuzawa Y., Shimomura I., Shinomura Y., Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease. Gut 2005 54 6 789 796 2-s2.0-21144434528 10.1136/gut.2004.046516 (Pubitemid 40732095)
80. Rodrigues V. S., Milanski M., Fagundes J. J., Serum levels and mesenteric fat tissue expression of adiponectin and leptin in patients with Crohn's disease. Clinical & Experimental Immunology 2012 170 3 358 364 10.1111/j.1365-2249.2012.04660.x
81. Chandran M., Phillips S. A., Ciaraldi T., Henry R. R., Adiponectin: more than just another fat cell hormone? Diabetes Care 2003 26 8 2442 2450 2-s2.0-0043025533 10.2337/diacare.26.8.2442 (Pubitemid 36993340)
82. Schaffler A., Scholmerich J., Buchler C., Mechanisms of disease: adipocytokines and visceral adipose tissue-emerging role in intestinal and mesenteric diseases. Nature Clinical Practice Gastroenterology & Hepatology 2005 2 2 103 111 (Pubitemid 40790157)
83. Schäffler A., Herfarth H., Creeping fat in Crohn's disease: travelling in a creeper lane of research. Gut 2005 54 6 742 744 2-s2.0-19544390537 10.1136/gut.2004.061531 (Pubitemid 40732083)
84. Weigert J., Obermeier F., Neumeier M., Wanninger J., Filarsky M., Bauer S., Aslanidis C., Rogler G., Ott C., Schäffler A., Schölmerich J., Buechler C., Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease. Inflammatory Bowel Diseases 2010 16 4 630 637 2-s2.0-77949525523 10.1002/ibd.21091
85. Valentini L., Wirth E. K., Schweizer U., Hengstermann S., Schaper L., Koernicke T., Dietz E., Norman K., Buning C., Winklhofer-Roob B. M., Lochs H., Ockenga J., Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease. Nutrition 2009 25 2 172 181 2-s2.0-58149472945 10.1016/j.nut.2008.07.020
86. Karmiris K., Koutroubakis I. E., Kouroumalis E. A., Leptin, adiponectin, resistin, and ghrelin-implications for inflammatory bowel disease. Molecular Nutrition and Food Research 2008 52 8 855 866 2-s2.0-49549091196 10.1002/mnfr.200700050
87. Schäffler A., Schölmerich J., The role of adiponectin in inflammatory gastrointestinal diseases. Gut 2009 58 3 317 322 2-s2.0-61649124115 10.1136/gut.2008.159210
88. Schäffler A., Scholmerich J., Buchler C., Mechanisms of disease: adipocytokines and visceral adipose tissue-emerging role in intestinal and mesenteric diseases. Nature Reviews Gastroenterology and Hepatology 2005 2 2 103 111 10.1038/ncpgasthep0090 (Pubitemid 40790157)
89. Zulian A., Cancello R., Micheletto G., Gentilini D., Gilardini L., Danelli P., Invitti C., Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease? Gut 2012 61 1 86 94 2-s2.0-83555176392 10.1136/gutjnl-2011-300391
90. Paul G., Schäffler A., Neumeier M., Fürst A., Bataillle F., Buechler C., Müller-Ladner U., Schölmerich J., Rogler G., Herfarth H., Profiling adipocytokine secretion from creeping fat in Crohn's disease. Inflammatory Bowel Diseases 2006 12 6 471 477 2-s2.0-33745270586 10.1097/00054725-200606000-00005
91. Karmiris K., Koutroubakis I. E., Kouroumalis E. A., The emerging role of adipocytokines as inflammatory mediators in inflammatory bowel disease. Inflammatory Bowel Diseases 2005 11 9 847 855 2-s2.0-25444436668 10.1097/01.mib.0000178915.54264.8f (Pubitemid 41368274)
92. Bortoli A., Pedersen N., Duricova D., D'Inca R., Gionchetti P., Panelli M. R., Ardizzone S., Sanroman A. L., Gisbert J. P., Arena I., Riegler G., Marrollo M., Valpiani D., Corbellini A., Segato S., Castiglione F., Munkholm P., Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006. Alimentary Pharmacology and Therapeutics 2011 34 7 724 734 2-s2.0-80052449320 10.1111/j.1365-2036.2011. 04794.x
93. Pedersen B. K., Saltin B., Evidence for prescribing exercise as therapy in chronic disease. Scandinavian Journal of Medicine and Science in Sports 2006 16 1 3 63 2-s2.0-33645096520 10.1111/j.1600-0838.2006.00520.x (Pubitemid 43433766)
94. Febbraio M. A., Rose-John S., Pedersen B. K., Is interleukin-6 receptor blockade the holy grail for inflammatory diseases? Clinical Pharmacology and Therapeutics 2010 87 4 396 398 2-s2.0-77949842566 10.1038/clpt.2010.1
95. Keller C., Hellsten Y., Steensberg A., Klarlund Pedersen B., Differential regulation of IL-6 and TNF- α via calcineurin in human skeletal muscle cells. Cytokine 2006 36 3-4 141 147 2-s2.0-33847199401 10.1016/j.cyto.2006.10. 014
96. Ellingsgaard H., Hauselmann I., Schuler B., Habib A. M., Baggio L. L., Meier D. T., Eppler E., Bouzakri K., Wueest S., Muller Y. D., Hansen A. M. K., Reinecke M., Konrad D., Gassmann M., Reimann F., Halban P. A., Gromada J., Drucker D. J., Gribble F. M., Ehses J. A., Donath M. Y., Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nature Medicine 2011 17 11 1481 1489 2-s2.0-81255157471 10.1038/nm.2513
97. Brubaker P. L., Drucker D. J., Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology 2004 145 6 2653 2659 2-s2.0-2542479899 10.1210/en.2004-0015 (Pubitemid 38686211)
98. Drucker D. J., Yusta B., Boushey R. P., DeForest L., Brubaker P. L., Human [Gly2]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis. American Journal of Physiology: Gastrointestinal and Liver Physiology 1999 276 1 G79 G91 2-s2.0-0032621235 (Pubitemid 29063603)
99. Geier M. S., Tenikoff D., Yazbeck R., McCaughan G. W., Abbott C. A., Howarth G. S., Development and resolution of experimental colitis in mice with targeted deletion of dipeptidyl peptidase IV. Journal of Cellular Physiology 2005 204 2 687 692 2-s2.0-21644481903 10.1002/jcp.20333 (Pubitemid 40934665)
100. Yazbeck R., Howarth G. S., Geier M. S., Demuth H.-U., Abbott C. A., Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice. Frontiers in Bioscience 2008 13 18 6850 6858 2-s2.0-52049083870 10.2741/3193
101. Nielsen A. R., Mounier R., Plomgaard P., Mortensen O. H., Penkowa M., Speerschneider T., Pilegaard H., Pedersen B. K., Expression of interleukin-15 in human skeletal muscle-effect of exercise and muscle fibre type composition. The Journal of Physiology 2007 584 1 305 312 2-s2.0-34848878670 10.1113/jphysiol.2007.139618 (Pubitemid 47500557)
102. Quinn L. S., Anderson B. G., Strait-Bodey L., Stroud A. M., Argués J. M., Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. American Journal of Physiology: Endocrinology and Metabolism 2009 296 1 E191 E202 2-s2.0-58249096194 10.1152/ajpendo.90506.2008
103. Quinn L. S., Strait-Bodey L., Anderson B. G., Argilés J. M., Havel P. J., Interleukin-15 stimulates adiponectin secretion by 3T3-L1 adipocytes: Evidence for a skeletal muscle-to-fat signaling pathway. Cell Biology International 2005 29 6 449 457 2-s2.0-23044481429 10.1016/j.cellbi.2005.02.005 (Pubitemid 41073643)
104. Boström P., Wu J., Jedrychowski M. P., Korde A., Ye L., Lo J. C., Rasbach K. A., Boström E. A., Choi J. H., Long J. Z., Kajimura S., Zingaretti M. C., Vind B. F., Tu H., Cinti S., Højlund K., Gygi S. P., Spiegelman B. M., A PGC1- α -dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012 481 7382 463 468 2-s2.0-84856218208 10.1038/nature10777
105. Bostrom P. A., Graham E. L., Georgiadi A., Impact of exercise on muscle and nonmuscle organs. IUBMB Life 2013 65 10 845 850
106. Aoi W., Naito Y., Takagi T., A novel myokine, secreted protein acidic and rich in cysteine (SPARC), suppresses colon tumorigenesis via regular exercise. Gut 2013 62 6 882 889
107. Vadan R., Gheorghe L. S., Constantinescu A., Gheorghe C., The prevalence of malnutrition and the evolution of nutritional status in patients with moderate to severe forms of Crohn's disease treated with Infliximab. Clinical Nutrition 2011 30 1 86 91 2-s2.0-79451470968 10.1016/j.clnu.2010.07.019
108. Wiroth J.-B., Filippi J., Schneider S. M., Al-Jaouni R., Horvais N., Gavarry O., Bermon S., Hébuterne X., Muscle performance in patients with Crohn's disease in clinical remission. Inflammatory Bowel Diseases 2005 11 3 296 303 2-s2.0-15944376170 10.1097/01.MIB.0000160810.76729.9c (Pubitemid 40439684)
109. Schneider S., Al-Jaouni R., Filippi J., Wiroth J.-B., Zeanandin G., Arab K., Hébuterne X., Sarcopenia is prevalent in patients with Crohn's disease in clinical remission. Inflammatory Bowel Diseases 2008 14 11 1562 1568 2-s2.0-59249106322 10.1002/ibd.20504
110. van Langenberg D. R., Gatta P. D., Hill B., Delving into disability in Crohn's disease: dysregulation of molecular pathways may explain skeletal muscle loss in Crohn's disease. Journal of Crohn's and Colitis 2013 10.1016/j.crohns.2013.11.024
111. Shamir R., Phillip M., Levine A., Growth retardation in pediatric Crohn's disease: pathogenesis and interventions. Inflammatory Bowel Diseases 2007 13 5 620 628 2-s2.0-34249039928 10.1002/ibd.20115 (Pubitemid 46799646)
112. Frost R. A., Lang C. H., Alteration of somatotropic function by proinflammatory cytokines. Journal of Animal Science 2004 82 E100 E109 2-s2.0-17844371143
113. Frost R. A., Nystrom G. J., Jefferson L. S., Lang C. H., Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle. American Journal of Physiology: Endocrinology and Metabolism 2007 292 2 E501 E512 2-s2.0-33846875462 10.1152/ajpendo.00359.2006 (Pubitemid 46220575)
114. Lang C. H., Hong-Brown L., Frost R. A., Cytokine inhibition of JAK-STAT signaling: a new mechanism of growth hormone resistance. Pediatric Nephrology 2005 20 3 306 312 2-s2.0-14644404961 10.1007/s00467-004-1607-9 (Pubitemid 40309934)
115. Ballinger A., Fundamental mechanisms of growth failure in inflammatory bowel disease. Hormone Research 2002 58 1 7 10 2-s2.0-0036420357 (Pubitemid 35316829)
116. Ballinger A. B., Azooz O., El-Haj T., Poole S., Farthing M. J. G., Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut 2000 46 5 694 700 2-s2.0-0034021675 (Pubitemid 30305788)
117. Verdijk L. B., Gleeson B. G., Jonkers R. A. M., Meijer K., Savelberg H. H. C. M., Dendale P., van Loon L. J. C., Skeletal muscle hypertrophy following resistance training is accompanied by a fiber type-specific increase in satellite cell content in elderly men. Journals of Gerontology A 2009 64 3 332 339 2-s2.0-64849110613 10.1093/gerona/gln050
118. Hindi S. M., Mishra V., Bhatnagar S., Regulatory circuitry of TWEAK-Fn14 system and PGC-1a in skeletal muscle atrophy program. The FASEB Journal 2013 28 3 1398 1411
119. Tajrishi M. M., Zheng T. S., Burkly L. C., The TWEAK-Fn14 pathway: a potent regulator of skeletal muscle biology in health and disease. Cytokine & Growth Factor Reviews 2013
120. Uhrin Z., Kuzis S., Ward M. M., Exercise and changes in health status in patients with ankylosing spondylitis. Archives of Internal Medicine 2000 160 19 2969 2975 2-s2.0-0034706415 (Pubitemid 32009055)
121. Siffledeen J. S., Siminoski K., Jen H., Fedorak R. N., Vertebral fractures and role of low bone mineral density in Crohn's disease. Clinical Gastroenterology and Hepatology 2007 5 6 721 728 2-s2.0-34249722226 10.1016/j.cgh.2007.02.024 (Pubitemid 46830056)
122. Robinson R. J., Krzywicki T., Almond L., Al-Azzawi F., Abrams K., Iqbal S. J., Mayberry J. F., Effect of a low-impact exercise program on bone mineral density in Crohn's disease: a randomized controlled trial. Gastroenterology 1998 115 1 36 41 2-s2.0-0031748508 10.1016/S0016-5085(98)70362-2 (Pubitemid 28307285)
123. Lee N., Radford-Smith G. L., Forwood M., Wong J., Taaffe D. R., Body composition and muscle strength as predictors of bone mineral density in Crohn's disease. Journal of Bone and Mineral Metabolism 2009 27 4 456 463 2-s2.0-67749097503 10.1007/s00774-009-0059-5
124. Lee N., Radford-Smith G., Taaffe D. R., Bone loss in Crohn's disease: exercise as a potential countermeasure. Inflammatory Bowel Diseases 2005 11 12 1108 1118 2-s2.0-27944453906 10.1097/01.MIB.0000192325.28168.08 (Pubitemid 41682568)
125. Bilski J., Manko G., Brzozowski T., Effects of exercise of different intensity on gut peptides, energy intake and appetite in young males. Annals of Agricultural and Environmental Medicine 2013 20 4 787 793
126. Jaworek J., Bonior J., Konturek S. J., Bilski J., Szlachcic A., Pawlik W. W., Role of leptin in the control of postprandial pancreatic enzyme secretion. The Journal of Physiology and Pharmacology 2003 54 4 591 602 2-s2.0-0347993912 (Pubitemid 38029754)
127. Warzecha Z., Dembiński A., Ceranowicz P., Jaworek J., Konturek P. C., Dembiński M., Bilski J., Konturek S. J., Influence of leptin administration on the course of acute ischemic pancreatitis. The Journal of Physiology and Pharmacology 2002 53 4 775 790 2-s2.0-0036908441 (Pubitemid 36014789)
128. Ballinger A., Divergency of leptin response in intestinal inflammation. Gut 1999 44 5 588 589 2-s2.0-0033044544 (Pubitemid 29195898)
129. Minderhoud I. M., Samsom M., Oldenburg B., Crohn's disease, fatigue, and infliximab: is there a role for cytokines in the pathogenesis of fatigue? World Journal of Gastroenterology 2007 13 14 2089 2093 2-s2.0-34249085886 (Pubitemid 46795847)
130. van Langenberg D. R., Gibson P. R., Factors associated with physical and cognitive fatigue in patients with Crohn's Disease: a cross-sectional and longitudinal Study. Inflammatory Bowel Diseases 2014 20 1 115 125
131. Blondel-Kucharski F., Chircop C., Marquis P., Cortot A., Baron F., Gendre J.-P., Colombel J.-F., Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients. The American Journal of Gastroenterology 2001 96 10 2915 2920 2-s2.0-0034799299 10.1016/S0002-9270(01) 03243-9 (Pubitemid 32959533)
132. Minderhoud I. M., Oldenburg B., Wismeijer J. A., van Berge Henegouwen G. P., Smout A. J. P. M., IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Digestive Diseases and Sciences 2004 49 3 469 474 2-s2.0-1842608600 10.1023/B:DDAS.0000020506.84248.f9 (Pubitemid 38453568)
133. Ball E., Exercise guidelines for patients with inflammatory bowel disease. Gastroenterology Nursing 1998 21 3 108 111 10.1097/00001610-199805000- 00002
134. Gibala M. J., Little J. P., Macdonald M. J., Hawley J. A., Physiological adaptations to low-volume, high-intensity interval training in health and disease. The Journal of Physiology 2012 590 5 1077 1084 2-s2.0-84857672185 10.1113/jphysiol.2011.224725
135. Burgomaster K. A., Howarth K. R., Phillips S. M., Rakobowchuk M., Macdonald M. J., Mcgee S. L., Gibala M. J., Similar metabolic adaptations during exercise after low volume sprint interval and traditional endurance training in humans. The Journal of Physiology 2008 586 1 151 160 2-s2.0-37749021969 10.1113/jphysiol.2007.142109
136. Janssen I., LeBlanc A. G., Systematic review of the health benefits of physical activity and fitness in school-aged children and youth. International Journal of Behavioral Nutrition and Physical Activity 2010 7, article 40 2-s2.0-77951968604 10.1186/1479-5868-7-40
137. Tremaine W. J., Timmons L. J., Loftus E. V. Jr., Pardi D. S., Sandborn W. J., Harmsen W. S., Thapa P., Zinsmeister A. R., Age at onset of inflammatory bowel disease and the risk of surgery for non-neoplastic bowel disease. Alimentary Pharmacology and Therapeutics 2007 25 12 1435 1441 2-s2.0-34249808796 10.1111/j.1365-2036.2007.03341.x (Pubitemid 46848894)
138. Yeo N. H., Woo J., Shin K. O., The effects of different exercise intensity on myokine and angiogenesis factors. The Journal of Sports Medicine and Physical Fitness 2012 52 4 448
139. Elsenbruch S., Langhorst J., Popkirowa K., Müller T., Luedtke R., Franken U., Paul A., Spahn G., Michalsen A., Janssen O. E., Schedlowski M., Dobos G. J., Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis. Psychotherapy and Psychosomatics 2005 74 5 277 287 2-s2.0-23844441637 10.1159/000086318 (Pubitemid 41160198)